Abstract
We generated a novel human neutralizing human mAb RabD4 against rabies virus glycoprotein using in vitro stimulation of human peripheral B cells produced by immunized donor. The human mAb RabD4 showed a high antigen-binding activity and virus-neutralizing activity in the FAVN test with the CVS-11 rabies virus.
Similar content being viewed by others
REFERENCES
Fisher, C.R., Streicker, D.G., and Schnell, M.J., Nat. Rev. Microbiol., 2018, vol. 16, pp. 241–255.
Kohler, G. and Milstein, C., Nature, 1975, vol. 256, pp. 495–497.
Ilina, E.N., Solopova, O.N., Balabashin, D.S., Larina, M.V., Aliev, T.K., Grebennikova, T.V., Losich, M.A., Zaykova, O.N., Sveshnikov, P.G., Dolgikh, D.A., and Kirpichnikov, M.P., Russ. J. Bioorg. Chem., 2019, vol. 45, no. 1, pp. 1–11.
de Kruif, J., Bakker, A.B., Marissen, W.E., Kramer, R.A., Throsby, M., Rupprecht, C.E., and Goudsmit, J., Annu. Rev. Med., 2007, vol. 58, pp. 359–368.
Laemmli, U.K., Nature, 1970, vol. 227, pp. 680–685.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by M. Batrukova
Rights and permissions
About this article
Cite this article
Ilina, E.N., Solopova, E.V., Aliev, T.K. et al. The Generation of the Human mAb RabD4 Specific to the Rabies Virus Glycoprotein and Characterization Thereof. Dokl Biochem Biophys 485, 126–128 (2019). https://doi.org/10.1134/S1607672919020133
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672919020133